Proteinase K Market Segmentation, Forecast, Analysis, Industry Size And Share To 2027

The global proteinase K market size is predicted to reach US$ 107.5 Million by 2027 according to a new study by Polaris Market Research. The report “Proteinase K Market Share, Size, Trends, Industry Analysis Report, By Therapeutic Area (Infectious diseases, Diabetes, Oncology, Cardiology, Nephrology, Autoimmune diseases, Neurology, and Others); By Form (Powder, and Liquid), By Regions; Segment Forecast, 2020 – 2027” gives a detailed insight into current market dynamics and provides analysis on future market growth.

 

The global proteinase K demand is anticipated to grow owing to the increasing prevalence of COVID-19 cases, establishment of universities and government-funded laboratories, population-based studies, and innovations in bio-catalysts. Furthermore, the rising number of designated laboratories which perform western blotting, polymerase chain reaction, and in in-vitro research studies is expected to drive market demand for proteinase K.

 

The increasing market demand for proteinase K for pre-treatment of COVID-19 infections is expected to drive product demand. Furthermore, the increasing demand for point of care diagnostics and the growing utility of proteinase K in PoC is expected to drive market demand. In addition, the use of proteinase K for in situ hybridization is likely to complement the proteinase K industry growth.

 

Download Sample Copy : https://www.polarismarketresearch.com/industry-analysis/proteinase-k-market/request-for-sample

 

Segment Highlight

• The infectious diseases segment accounted for the largest revenue share in 2019 owing to the sudden spike in viral infections associated with COVID-19. In addition, the increasing demand for proteinase K for treatment of several infections is likely to complement market growth.

 

• Based on form, the proteinase K powdered segment is projected to constitute almost half of the market by the end of 2027. The segment holds the major market share due to its stability in the powered form and it is easy transport.

 

• North America accounted for the largest revenue market share in 2019. This can be attributed to sudden spike in COVID-19 infections, presence of key manufacturers in the market, and the government-sponsored population-based studies boosting the consumption of proteinase K.

 

List of Key Players

• Merck KGaA
• BBI Solutions
• Codexis, Inc.
• SBS Genetech Ltd.
• Hoffmann-La Roche Ltd
• Amicogen
• Amano Enzyme Inc.
• Advanced Enzymes Technologies Ltd
• Others

For Further Insights and Segment-Specific Information, Contact a Market Analyst at : https://www.polarismarketresearch.com/industry-analysis/proteinase-k-market/speak-to-analyst

 

Polaris Market Research has segmented the proteinase K market report on the basis of therapeutic area, by form, and geographic region.

 

Proteinase K, Therapeutic Area Outlook (Revenue – USD Million, 2016 – 2027)

• Infectious diseases
• Diabetes
• Oncology
• Cardiology
• Nephrology
• Autoimmune diseases
• Neurology
• Others

Proteinase K, Form Outlook (Revenue – USD Million, 2016 – 2027)

• Powder
• Liquid

Proteinase K Regional Outlook (Revenue – USD Million, 2016 – 2027)

• North America (U.S., Canada)
• Europe (France, Germany, UK, Spain, Netherlands, Austria)
• Asia Pacific (Japan, China, India, Malaysia, Indonesia. South Korea)
• Latin America (Brazil, Mexico, Argentina)
• MEA (Saudi Arabia, UAE, Israel, South Africa)

Read More : https://www.medgadget.com/2021/02/proteinase-k-market-size-is-projected-to-reach-107-5-million-by-2027-exclusive-study-by-polaris-market-research.html

 

Point of Care (PoC) Diagnostics Market Overview, Growth Factors, Demand and Trends Forecast to 2028

The global Point of Care (PoC) diagnostics market is expected to reach US$ 24.70 billion by 2028, according to a new study by Polaris Market Research. The report “Point of Care (PoC) Diagnostics Market Share, Size, Trends, Industry Analysis Report, By Platform (Lateral Flow Assays, Dipsticks, Microfluidics, Molecular Diagnostics, Immunoassays); By End-Use (Clinics, Hospitals, Home, Assisted Living Healthcare Facilities, Laboratory); By Product; By Regions; Segment Forecast, 2021 – 2028” gives a detailed insight into current market dynamics and provides analysis on future market growth.

 

The global Point of Care (PoC) diagnostics market is driven by continuous technological advancement in the form of miniaturization of devices, growing preference of patients towards home care, and consistent decline in prices due to inflow of innovative market players. Price reduction increases product penetration, owing to higher affordability among consumers.

 

The growing prevalence of target diseases such as cancer, diabetes, cardiovascular diseases and infectious diseases is expected to drive Point of Care (PoC) diagnostics industry. Cardiovascular diseases are one of the most fatal disorders and are the leading cause of death across the globe. The high presence of unmet medical needs pertaining to this disease and the subsequent rise observe in patient awareness levels in this region is expected to boost the demand for Point of Care (PoC) diagnostics.

 

Download Sample Copy : https://www.polarismarketresearch.com/industry-analysis/point-of-care-poc-diagnostics-market/request-for-sample

 

Segment Highlights

·         Glucose testing segment accounted for the largest revenue share in 2020. Regular glucose testing is of paramount importance for diabetic patients. As per the Diabetes Control and Complications Trial, the use of blood glucose monitors leads to lesser disease complications. Point of Care (PoC) glucose monitors assisting in periodic monitoring of blood glucose helps doctors decide suitable treatment patterns.

·         Clinics were the largest end-use segment accounting for major market share in 2020. High procedure volumes associated with these establishments is one of the primary reasons attributing to its large share.

·         North America was the largest regional market for revenue generation in from Point of Care (PoC) devices in 2020. Growing geriatric population base and the presence of higher medical expenditure levels are some key factors attributing to its largest share.

·         The leading players in the point of care (PoC) diagnostic market include Sekisui Diagnostics LLC, Trinity Biotech PLC, International Technidyne Corporation (ITC), Nipro Diagnostics Inc, Becton Dickinson & Company, Danaher Corporation, Siemens Healthcare GmbH, Roche Ltd.

 

List of Key Players of Point of Care (PoC) Diagnostics Industry

• Roche Diagnostics
• EKF Diagnostics
• Siemens Healthineers
• Chembio Diagnostic Systems
• Johnson & Johnson
• Abbott Laboratories
• Becton, Dickinson and Company
• Danaher Corporation
• Quidel Corporation
• Nova Biomedical
• PTS Diagnostics
• Sekisui Diagnostics.
• Others

For Further Insights and Segment-Specific Information, Contact a Market Analyst at : https://www.polarismarketresearch.com/industry-analysis/point-of-care-poc-diagnostics-market/request-for-customization 

Polaris Market Research has segmented the Point of Care (PoC) diagnostics market report on the basis of product, platform, end-use, and region

 

Point of Care (PoC) Diagnostics, Product Outlook (Revenue – USD Million, 2016 – 2028)

• Glucose Testing
• Hb1Ac Testing
• Coagulation
• Fertility
• Infectious Diseases
• HIV
• Clostridium Difficile
• HBV
• Pneumonia or Streptococcus Associated Infections
• Respiratory Syncytial Virus (RSV)
• HPV
• Influenza/Flu
• HCV
• MRSA
• TB and Drug-Resistant TB
• HSV
• Others
• Cardiac Markers
• Thyroid Stimulating Hormone
• Hematology
• Primary Care Systems
• Decentralized Clinical Chemistry
• Feces
• Lipid Testing
• Cancer Marker
• Blood Gas/Electrolytes
• Ambulatory Chemistry
• Drug Abuse Testing
• Urinalysis

Point of Care (PoC) Diagnostics, Platform Outlook (Revenue – USD Million, 2016 – 2028)

• Lateral Flow Assays
• Dipsticks
• Microfluidics
• Molecular Diagnostics
• Immunoassays

Point of Care (PoC) Diagnostics, End-Use Outlook (Revenue – USD Million, 2016 – 2028)

• Clinics
• Physician Office
• Pharmacy & Retail Clinics
• Non-practice Clinics
• Urgent Care Clinic
• Hospitals
• Home
• Assisted Living Healthcare Facilities
• Laboratory

 

Point of Care (PoC) Diagnostics Regional Outlook (Revenue – USD Million, 2016 – 2028)

·         North America (U.S., Canada)

·         Europe (France, Germany, UK, Italy, Spain, Netherlands, Austria)

·         Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea)

·         Latin America (Brazil, Mexico, Argentina)

·         Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

 

Read More : https://www.medgadget.com/2021/02/point-of-care-poc-diagnostics-market-size-worth-24-70-billion-by-2028-exclusive-study-by-polaris-market-research.html

 

 

 

Sepsis Diagnostics Market Growth Factors, Types, Application and Regional Geography

 The global sepsis diagnostics market size is predicted to reach USD 1.03 billion by 2027 according to a new study by Polaris Market Research. The report “Sepsis Diagnostics Market Share, Size, Trends, Industry Analysis Report, By Product (Instruments, Blood Culture Media, Assay Kits & Reagents, Software); By Technology (Microbiology, Molecular Diagnostics, Biomarkers, Immunoassays, Flow Cytometry); By Pathogen (Bacterial Sepsis, Fungal Sepsis, Others); By Testing Type (Laboratory Testing, PoC Testing); By Regions; Segment Forecast, 2020 – 2027” gives a detailed insight into current market dynamics and provides analysis on future market growth.

 

The key factors responsible for the market growth include innovations in biomarker-based sepsis diagnosis; growing medical attention towards ill effects of sepsis and its economic burden; and the development of technologically advanced rapid PoC diagnosis systems. Moreover, the favorable reimburse scenario in developed economies and burgeoning healthcare infrastructure in low and middle-income countries is expected to propel market growth.

 

The market is fragmented based on product, technology, pathogen, type, and region. In terms of product, the market is segmented into instruments, blood culture media, assay kits and reagents, and software. Based on technology, the market is further bifurcated into microbiology, molecular diagnostics, biomarkers, immunoassays, and flow cytometry. Based on pathogen, the market is classified as bacterial sepsis, fungal sepsis, and others. The type segment is further divided into laboratory testing, and PoC testing.

 

Download Sample Copy : https://www.polarismarketresearch.com/industry-analysis/global-sepsis-diagnostics-market/request-for-sample

 

Segment Highlight

• The blood culture media segment accounted for the largest revenue share of the global market as it is used in maximum cases for diagnosis. However, the kits & reagents market segment is expected to witness fastest growth over the forecast period.
• Microbiology technology segment is expected to account for the largest revenue share by the end of 2027 as the technology aids in quantitative identification and detection of microorganisms through culture media tests
• Laboratory testing segment is expected to witness significant growth over the forecast period on account of the increasing number of blood cultures conducted in laboratories across the globe
• North America region is dominating the market, holding a significant market share throughout the forecast period. The presence of major players in the region, industry-academia collaboration, and intellectual capability of the U.S. are major factors responsible for the region’s growth

 

List of Key Players

• bioMérieux
• Becton Dickinson
• Danaher Corporation
• Abbott Laboratories
• Thermo Fisher Scientific
• EKF Diagnostics
• Roche Diagnostics
• Others

 

For Further Insights and Segment-Specific Information, Contact a Market Analyst at : https://www.polarismarketresearch.com/industry-analysis/global-sepsis-diagnostics-market/request-for-customization

 

Polaris Market Research has segmented the sepsis diagnostics market report on the basis of product, technology, pathogen, type, and region:

 

Sepsis Diagnostics, Product Outlook (Revenue – USD Million, 2016 – 2027)

• Instruments
• Blood Culture Media
• Assay Kits & Reagents
• Software

Sepsis Diagnostics, Technology Outlook (Revenue – USD Million, 2016 – 2027)

• Microbiology
• Molecular Diagnostics
• Immunoassays
• Flow Cytometry

Sepsis Diagnostics, Pathogen Outlook (Revenue – USD Million, 2016 – 2027)

• Bacterial Sepsis
• Gram-Positive Bacteria
• Gram-Negative Bacteria
• Fungal Sepsis
• Others

Sepsis Diagnostics, Type Outlook (Revenue – USD Million, 2016 – 2027)

• Laboratory Testing
• PoC Testing

Sepsis Diagnostics, Regional Outlook (Revenue – USD Million, 2016 – 2027)

• North America (U.S., Canada)
• Europe (France, Germany, UK, Italy, Spain, Netherlands, Austria)
• Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea)
• Latin America (Brazil, Mexico, Argentina)
• Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

Read More : https://www.medgadget.com/2021/02/sepsis-diagnostics-market-size-is-projected-to-reach-us-1-03-billion-by-2027-exclusive-study-by-polaris-market-research.html

Cannabis Pharmaceuticals Market 2021-2028 | Latest COVID19 Impact Analysis

 

The global cannabis pharmaceuticals market is expected to reach USD 5.72 billion by 2027, according to a new study by Polaris Market Research. The report “Cannabis Pharmaceuticals Market Share, Size, Trends, Industry Analysis Report, By Product (Epidiolex, Marinol, Cesamet and Sativex); By Distribution Channel (Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies), By Regions; Segment Forecast, 2020 – 2027” gives a detailed insight into current market dynamics and provides analysis on future market growth.

 

Favorable legislation in the market, policies across developed economies, and investments in the research and development for cannabis-infused drugs are the key factors responsible for the market growth. Moreover, technological innovation to decide the accurate dose of cannabis-infused drugs with cutting edge delivery methods to ensure therapeutic and psychoactive events, to contain drug abuse among adults also favoring market growth for cannabis pharmaceuticals. Blockchain technology in the pharmaceutical industry could be used to maintain strain purity and product formulations to have effective treatment for the therapeutic cause and will also enable us to capture dosage data for future considerations, thus technology could also play important role in shaping the market future of the cannabis pharmaceuticals industry.

 

The global market for cannabis pharmaceuticals is fragmented based on product, distribution channel, and region. In terms of product, the market is segmented into Epidiolex, Marinol, Cesamet, and Sativex. Based on distribution channel, the cannabis pharmaceuticals industry is further bifurcated into hospital, online, and retail pharmacies.

 

Download Sample Copy : https://www.polarismarketresearch.com/industry-analysis/cannabis-pharmaceuticals-market/request-for-sample

 

Segment Highlights

• Sativex segment accounted for the largest revenue share in 2019 owing to the growing usage of drug for the muscle spasticity. In addition, growing demand for plant-based pharmaceuticals is expected to drive market demand for cannabis pharmaceuticals.
• Based on distribution channel, the hospitals pharmacies segment is projected to account for a significant share by 2027. The high share is attributed to the fact that most of the physicians recommend medicines from in-house pharmacy stores driving the cannabis medicines market growth.
• Europe accounted for the largest share in 2019 in terms of revenue on account of the increasing demand for plant-based medicines and the increasing awareness pertaining to the medicinal benefits associated cannabis

 

List of Key Players

• GW Pharmaceuticals
• Valeant Pharmaceuticals
• Insys Therapeutics, Inc.
• Corbus Pharmaceuticals
• Teva Pharmaceutical
• Avicanna
• Solvay Pharmaceuticals
• Cannabics Pharmaceuticals
• Others

 

For Further Insights and Segment-Specific Information, Contact a Market Analyst at : https://www.polarismarketresearch.com/industry-analysis/cannabis-pharmaceuticals-market/request-for-customization

 

Polaris Market Research has segmented the cannabis pharmaceuticals market report on the basis of product, distribution channel, and region

 

Cannabis Pharmaceuticals, Product Outlook (Revenue – USD Million, 2016 – 2027)

• Sativex
• Marinol
• Cesamet
• Epidiolex

Cannabis Pharmaceuticals, Distribution Channel Outlook (Revenue – USD Million, 2016 – 2027)

• Hospital Pharmacies
• Online Pharmacies
• Retail Pharmacies

Cannabis Pharmaceuticals, Regional Outlook (Revenue – USD Million, 2016 – 2027)

 

• North America (U.S., Canada)
• Europe (France, Germany, UK, Italy, Spain, Netherlands, Austria)
• Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea)
• Latin America (Brazil, Mexico, Argentina)
• Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

Read More : https://www.medgadget.com/2021/02/cannabis-pharmaceuticals-market-to-surpass-5-72-billion-by-2027-cagr-75-8-polaris-market-research.html

 

 

 

 

Hospital outsourcing Market Growth Factors, Types, Application and Regional Geography

 

The global hospital outsourcing market expected to Reach $579.58 Billion by 2027 according to a new study by Polaris Market Research. The report “Hospital Outsourcing Market Share, Size, Trends, Industry Analysis Report, By Service (Healthcare IT, Clinical services, Business services, Transportation services, Others); By Type (Public, Private); By Regions (North America, Europe, Asia Pacific, Latin America, Middle East & Africa); Segment Forecast, 2020 – 2027”

 

The global market for hospital outsourcing industry is anticipated to witness growth owing to the increasing cost-liabilities on hospitals, increased focus on value-based healthcare, consistent rise in chronic diseases due to lifestyle changes, and a subsequent rise in hospital admissions. To optimize costs, hospitals relying on IT transformation projects.

 

The global hospital outsourcing industry is fragmented based on service, type, and region. In terms of service, the market is segmented into healthcare IT, clinical services, business services, transportation services, and others. The type segment is further divided into public and private hospitals outsourcing.

 

Download Sample Copy : https://www.polarismarketresearch.com/industry-analysis/hospital-outsourcing-market/request-for-sample

 

Segment Highlights

• Other services market segment is estimated to hold a significant share in the global hospital outsourcing industry owing to high burden of ancillary non-productive services. Segment holds more than 40%% of the global share in 2019. However, clinical services segment is expected to expand at highest market growth during the forecast.
• Based on type, the private hospitals market segment is projected to constitute almost half of the market in 2027. High share is due to the cost-sensitive nature of private hospitals. To maintain financial leverage, these entities need to optimize cost structure.
• North America market is dominating the global hospital outsourcing industry accounting for over 60% of the revenue share throughout the forecast period. Inconsistent government policies and unsustainable hospital functioning model boosting the need for outsourcing services in the region
• The market players including Cerner Corporation, Aramark Corporation, and Integrated Medical Transport together held a significant market share in terms of revenue of global medical outsourcing industry in 2019.

 

List of Key Players

• Cerner Corporation
• LogistiCare Solutions
• The Allure Group
• Aramark Corporation, LLC
• Integrated Medical Transport
• Alere, Inc.
• ABM Industries Inc.
• Others

For Further Insights and Segment-Specific Information, Contact a Market Analyst at : https://www.polarismarketresearch.com/industry-analysis/hospital-outsourcing-market/request-for-customization

 

Polaris Market Research has segmented the hospital outsourcing market report on the basis of service, type, and region

Hospital Outsourcing, Service Outlook (Revenue – USD Million, 2016 – 2027)

• Healthcare IT
• Clinical services
• Business services
• Transportation services
• Others

Hospital Outsourcing, Type Outlook (Revenue – USD Million, 2016 – 2027)

• Public
• Private

Hospital Outsourcing, Regional Outlook (Revenue – USD Million, 2016 – 2027)

• North America (U.S., Canada)
• Europe (France, Germany, UK, Italy, Spain, Netherlands, Austria)
• Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea)
• Latin America (Brazil, Mexico, Argentina)
• Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

Read More : https://www.medgadget.com/2021/02/hospital-outsourcing-market-size-is-projected-to-reach-579-58-billion-by-2027-cagr-10-2-polaris-market-research.html

 

Flow Diverters Market 2021-2028 | Latest COVID19 Impact Analysis

 The global flow diverters market expected to reach US$ 566.7 million by 2027 according to a new study by Polaris Market Research. The report “Flow Diverters Market Share, Size, Trends, Industry Analysis Report, By Device Type; By Diameter Size (2-3 mm, 3-4 mm, 4-5 mm, >5 mm Flow Diverters); By Material (Cobalt-Chromium, Nickel-Cobalt Chromium, Nickel-Titanium, Stainless Steel); By Regions; Segment Forecast, 2020 – 2027” gives a detailed insight into current market dynamics and provides analysis on future market growth.

The market is expected to witness growth on account of advancements in neurology market, increasing investment in research & development into treating intra-cranial injuries, the aging population across several countries, particularly, in the European market, due to decline in birth rates, rising prevalence of brain injuries in road traffic accidents, and recreational sports.

Download Sample Copy : https://www.polarismarketresearch.com/industry-analysis/flow-diverters-market/request-for-sample

The global flow diverters industry is fragmented based on device type, diameter size, material, and region. In terms of device type, the market is segmented into PED, p64, Silk flow, Surpass flow and FRED flow diverters. The diameter size segment is further divided into 2-3 mm, 3-4 mm, 4-5 mm, and >5 mm flow diverters. In terms of material, the market is segmented into cobalt-chromium, nickel-cobalt chromium, nickel-titanium, and stainless steel.

Segment Highlights

• The PED segment accounted for significant share in terms of revenue owing to its high efficiency and product availability. The SILK flow market is expected to expand at highest CAGR during the forecast period.
• Based on diameter size, the >5 mm segment is projected to constitute almost half of the market in 2027. This can be attributed to the use of 5mm to treat severe intracranial aneurysms and in several implants
• Based on material, the nickel cobalt nickel chromium market segment is projected to account for a significant revenue share owing to its flexibility and less reactivity with body tissues while used as an implant

List of Key Players

• Medtronic
• MicroVention, Inc.
• Penumbra Inc.
• BALT Extrusion SA
• Stryker Corporation
• MicroPort Scientific Corporation
• Phenox GmbH
• Acandis
• Others

For Further Insights and Segment-Specific Information, Contact a Market Analyst at : https://www.polarismarketresearch.com/industry-analysis/flow-diverters-market/request-for-customization

Polaris Market research has segmented the flow diverters market report on the basis of device type, diameter size, material, and region.

Flow Diverters, Device Type Outlook (Revenue – USD Million, 2016 – 2027)

• Pipeline flex embolization device (PED)
• Silk flow diverter (SILK)
• Surpass flow diverter (SURPASS)
• FRED flow diverter
• p64 flow diverter

Flow Diverters, Diameter Size Outlook (Revenue – USD Million, 2016 – 2027)

• 2-3 mm
• 3-4 mm
• 4-5 mm
• >5 mm

Flow Diverters, Material Outlook (Revenue – USD Million, 2016 – 2027)

• Cobalt-chromium
• Nickel-cobalt chromium
• Nickel-titanium
• Stainless steel

Flow Diverter, Regional Outlook (Revenue – USD Million, 2016 – 2027)

• North America (U.S., Canada)
• Europe (France, Germany, UK, Italy, Spain, Netherlands, Austria)
• Asia Pacific (Japan, China, India, Malaysia, Indonesia. South Korea)
• Latin America (Brazil, Mexico, Argentina)
• MEA (Saudi Arabia, UAE, Israel, South Africa)

Read More : https://www.medgadget.com/2021/02/flow-diverters-market-size-is-projected-to-reach-566-7-million-by-2027-cagr-12-6-polaris-market-research.html

Automotive Suspension Market Size Historical Growth, Analysis, Opportunities and Forecast

The worldwide Automotive Suspension Market is anticipated to reach USD 127.6 billion by 2026 according to a new study published by Polaris Market Research. In 2017, the passenger cars segment dominated the global market, in terms of revenue. In 2017, North America accounted for the majority share in the global automotive suspension market.

 

The increasing need to offer high quality driving experience along with enhanced comfort and safety drives the automotive suspension market growth. The increasing production of motor vehicles across the world, and growing popularity of luxury automobiles boosts the adoption of automotive suspension.  The growing safety concerns have encouraged market players to integrate advanced automotive suspension systems in vehicles to improve the overall driving experience. Factors such as technological advancements, and use of light-weight material for suspension systems would fuel the automotive suspension market growth during the forecast period. New emerging markets, increasing demand of automobiles, and growing safety concerns are factors expected to influence the market in the coming years.

 

request a sample of the study on @ https://www.polarismarketresearch.com/industry-analysis/automotive-suspension-market/request-for-sample

 

 

Asia-Pacific is expected to lead the global automotive suspension market during the forecast period. Significant investment by market players to improve driving experience coupled with favorable regulations regarding transportation safety drive the growth of Automotive Suspension market in this region. Technological advancement and introduction of advanced automotive suspension systems by the market players has increased the acceptance of automotive suspension systems in the region. The rising demand for luxury vehicles, and economic growth in countries such as China and India boost the market growth in the region. Expansion of global players into these countries to tap market potential boosts the market growth.

 

The key players operating in the automotive suspension market include Multimatic Inc., Continental AG, Tenneco Inc., ZF TRW, Hendrickson USA, L.L.C, Thyssenkrupp AG, Magneti Marelli S.p.A, Sogefi SpA, WABCO Holdings Inc., and NHK Spring Co., Ltd. These companies launch new products and collaborate with other market leaders to innovate and launch new products to meet the increasing needs and requirements of consumers.

 

Speak to Analyst to know more @   https://www.polarismarketresearch.com/industry-analysis/automotive-suspension-market/speak-to-analyst